Article info

Download PDFPDF
Bet 2: Doxapram resurrected? Weak evidence of efficacy suggests a potential use in patients ineligible for non-invasive ventilation

Citation

Bet 2: Doxapram resurrected? Weak evidence of efficacy suggests a potential use in patients ineligible for non-invasive ventilation

Publication history

  • First published December 20, 2011.
Online issue publication 
December 20, 2011

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.